The model uses routine clinical data to predict persistent SA-AKI in patients with sepsis in the ICU environment quite well, and its diagnostic performance is even superior to that of CCL14, a biomarker known for diagnosing persistent SA-AKI. This evidence concerns the gene CCL14 and acute kidney injury.